These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 34804905)

  • 21. Spectrum of magnetic resonance imaging findings in post-COVID-19 patients presenting with rhino-orbito-cerebral mucormycosis in a teaching hospital in Malwa region of Punjab.
    Singh P; Kaur K; Jindal V; Kaur M; Kaur M; Singh N
    J Family Med Prim Care; 2022 Dec; 11(12):7788-7794. PubMed ID: 36994047
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rhino-orbital mucormycosis: Our experiences with clinical features and management in a tertiary care center.
    Singh SP; Rana J; Singh VK; Singh R; Sachan R; Singh S; Jain S
    Rom J Ophthalmol; 2021; 65(4):339-353. PubMed ID: 35087975
    [No Abstract]   [Full Text] [Related]  

  • 23. COVID-19 Associated Mucormycosis with Newly Diagnosed Diabetes Mellitus in Young Males - A Tertiary Care Experience.
    Kapoor S; Saidha PK; Gupta A; Saini U; Satya S
    Int Arch Otorhinolaryngol; 2022 Jul; 26(3):e470-e477. PubMed ID: 35846801
    [No Abstract]   [Full Text] [Related]  

  • 24. Clinical Profile of Central Nervous System Involvement in Patients with Rhino Orbital Cerebral Mucormycosis.
    Yadav S; Bs N; Ak S
    J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443423
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hit or Miss: The Dilemma of Specimen Selection for Microbiological Diagnosis of Rhino-Orbital-Cerebral- COVID-Associated Mucormycosis (ROCM-CAM).
    Jain V; Aggarwal A; Shrimali T; Vishwakarma K; Paul D; Kombade SP; Sharma V; Soni K; Choudhary B; Goyal A; Chugh A; Tiwari S; Sharma DK; Agarwal A; Misra S
    Infect Disord Drug Targets; 2023; 23(1):e160822207524. PubMed ID: 35975857
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rhino-orbito-cerebral mucormycosis. Management strategies to avoid or limit intracraneal affection and improve survival.
    Plowes Hernández O; Prado Calleros HM; Soberón Marmissolle Daguerre GS; Sadek González A
    Acta Otorrinolaringol Esp; 2015; 66(6):348-52. PubMed ID: 26048708
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mortality and its determinants after an outbreak of post COVID-19 associated rhino-orbito-cerebral mucormycosis in Central India.
    Nagarkar NM; Sahu V; Arora R; Pathak M; Shambharkar MS; Naveen P
    Int Ophthalmol; 2023 Jul; 43(7):2363-2370. PubMed ID: 36645635
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rhino-orbital and rhino-orbito-cerebral mucormycosis.
    Talmi YP; Goldschmied-Reouven A; Bakon M; Barshack I; Wolf M; Horowitz Z; Berkowicz M; Keller N; Kronenberg J
    Otolaryngol Head Neck Surg; 2002 Jul; 127(1):22-31. PubMed ID: 12161726
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Managing mucormycosis in diabetic patients: A case report with critical review of the literature.
    Beiglboeck FM; Theofilou NE; Fuchs MD; Wiesli MG; Leiggener C; Igelbrink S; Augello M
    Oral Dis; 2022 Apr; 28(3):568-576. PubMed ID: 33583133
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Management of Mucormycosis in Post COVID-19 Patients and Its Outcome in a Tertiary Care Center: Our Experience.
    Rao KM; Pooja N
    Indian J Otolaryngol Head Neck Surg; 2022 Oct; 74(Suppl 2):3344-3351. PubMed ID: 36267489
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Cross-Sectional Study of First Hundred Cases of Rhino-Orbital-Cerebral Mucormycosis Admitted at a Tertiary Care Hospital.
    Poswal L; Bunkar GL; Sharma R; Jain A; Samar N; Mathur N; Singh M; Kaushik PB
    Indian J Community Med; 2022; 47(3):433-436. PubMed ID: 36438531
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rhino-Orbito-Cerebral-Mucormycosis During the COVID-19 Second Wave in 2021 - A Preliminary Report from a Single Hospital.
    Arora R; Goel R; Khanam S; Kumar S; Shah S; Singh S; Chhabra M; Meher R; Khurana N; Sagar T; Kumar S; Garg S; Kumar J; Saxena S; Pant R
    Clin Ophthalmol; 2021; 15():3505-3514. PubMed ID: 34429582
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combination antifungal therapy without craniotomy in an immunocompromised patient with rhino-orbito-cerebral mucormycosis: A case report.
    Salehi M; Shahi F; Rizvi FS; Ghaderkhani S; Zainaldain H; Khodavaisy S; Jamali-Moghaddam SR; Dehghan Manshadi SA; Rezahosseini O
    Caspian J Intern Med; 2020; 11(2):227-230. PubMed ID: 32509254
    [TBL] [Abstract][Full Text] [Related]  

  • 34. COVID-19 associated rhino-orbital-cerebral mucormycosis-an institutional series.
    Naruka S; Rana N; Singh N; Kishore A; Nagpal K
    Ear Nose Throat J; 2024 Jun; 103(1_suppl):134S-144S. PubMed ID: 35176884
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rhino-orbital-cerebral mucormycosis: An epidemiological study from a tertiary care referral center in Western India.
    Patel R; Jethva J; Bhagat PR; Prajapati V; Thakkar H; Prajapati K
    Indian J Ophthalmol; 2022 Apr; 70(4):1371-1375. PubMed ID: 35326057
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rhino-Orbito-Cerebral Mucormycosis During the Second Wave of Covid-19: The Indian Scenario.
    Bhardwaj R; Sharma A; Parasher A; Gupta H; Sahu S; Pal S
    Indian J Otolaryngol Head Neck Surg; 2022 Oct; 74(Suppl 2):3492-3497. PubMed ID: 34786356
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Outcomes and factors affecting them in patients with rhino-orbito-cerebral mucormycosis.
    Kashkouli MB; Abdolalizadeh P; Oghazian M; Hadi Y; Karimi N; Ghazizadeh M
    Br J Ophthalmol; 2019 Oct; 103(10):1460-1465. PubMed ID: 30514712
    [TBL] [Abstract][Full Text] [Related]  

  • 38. COVID-19-related Rhino-orbital-cerebral Mucormycosis.
    Al-Ani RM; Al Tameemi KM
    Qatar Med J; 2022; 2022(4):47. PubMed ID: 36258686
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rhino-orbital-cerebral-mucormycosis in COVID-19: A systematic review.
    Bhattacharyya A; Sarma P; Sharma DJ; Das KK; Kaur H; Prajapat M; Kumar S; Bansal S; Prakash A; Avti P; Thota P; Reddy DH; Gautam BS; Medhi B
    Indian J Pharmacol; 2021; 53(4):317-327. PubMed ID: 34414911
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk factors and outcomes of COVID associated mucormycosis in kidney transplant recipients.
    Bansal SB; Rana A; Babras M; Yadav D; Jha P; Jain M; Sethi SK
    Transpl Infect Dis; 2022 Apr; 24(2):e13777. PubMed ID: 34932870
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.